SARO reports after the bell tomorrow with two signals pulling in opposite directions: the CEO has been steadily selling stock for weeks, while options positioning has shifted more defensive than at any point in recent months.
The options move is the sharper signal heading into the print. The put/call ratio has climbed to 0.36 — roughly double its 20-day average of 0.18 and well above where it has traded for most of the past three months. That puts it about 1.5 standard deviations above the norm, marking a meaningful step-up in demand for downside protection even as the stock has drifted quietly higher, gaining about 1.9% over the past month to $30.68. Borrow conditions offer no particular drama: availability is loose at over 400% of shares short, and borrowing costs are running below 0.6% annually — there is no squeeze pressure in the lending market.
The CEO selling is the harder signal to ignore. Russell Ford, Chairman and CEO, sold 40,000 shares on four consecutive trading days in early July — 160,000 shares in total, worth roughly $4.8 million at prices around $30. Those sales came at prices close to where the stock trades today, suggesting Ford was not selling into strength. Analyst moves reinforce the cautious undertone: the most recent analyst action, from Jefferies in early June, was a downgrade to Hold with a target cut to $30 — essentially in line with the current price. The broader Street consensus has edged lower over recent months, with Morgan Stanley, Susquehanna, RBC Capital, and others all trimming targets after the prior earnings print.
The fundamental debate is straightforward. Bulls point to StandardAero's engine aftermarket franchise — its 100% OEM licensing track record, growing component repair volume, and exposure to both commercial aerospace recovery and rising defense spending. Bears flag the near-term headwinds: government shutdown drag on the CRS segment, supply chain constraints, and limited visibility on LEAP volume execution. The mean analyst price target of $35.50 implies about 16% upside from current levels, though the gap between the most constructive targets (Susquehanna at $37, RBC at $34) and the most cautious (Jefferies at $30) is narrow — the Street isn't particularly split on valuation, just on whether the company can execute. T. Rowe Price's Q2 addition of more than 26 million shares makes them by far the largest institutional holder at nearly 16% of shares outstanding — a vote of long-term confidence that sits awkwardly alongside the CEO's recent exit.
Past earnings prints for SARO have tended to move the stock materially in both directions: the two most recent produced a 3.8% and a 6.6% gain on the day, though the print before those saw a 4.3% drop. Tomorrow's report is therefore less a referendum on the long-term aftermarket thesis and more a test of whether StandardAero can show progress on CRS margin recovery and LEAP deliveries at a level that convinces a cautious Street — and perhaps the CEO himself — that the stock deserves more than a hold rating at $30.
See the live data behind this article on ORTEX.
Open SARO on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
